Sign In
Buy SILK
$27.49
+0 (+0%)
At Close: Dec 13, 2024
Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
11:25am, Monday, 08'th Apr 2024
Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
04:30pm, Tuesday, 02'nd Apr 2024
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch o
Silk Road Medical (SILK) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Friday, 22'nd Mar 2024
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio
08:56am, Thursday, 07'th Mar 2024
Silk Road Medical (SILK) announces the launch of its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
09:00am, Tuesday, 05'th Mar 2024
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has
Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript
11:24pm, Wednesday, 28'th Feb 2024
Silk Road Medical, Inc (SILK) Q4 2023 Earnings Call Transcript
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
07:21pm, Wednesday, 28'th Feb 2024
Silk Road Medical (SILK) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.34 per share a year ago.
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
04:05pm, Wednesday, 28'th Feb 2024
SUNNYVALE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
04:30pm, Wednesday, 07'th Feb 2024
SUNNYVALE, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report
Silk Road Medical (SILK) Stock Jumps 12.7%: Will It Continue to Soar?
08:31am, Monday, 22'nd Jan 2024
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:30pm, Wednesday, 20'th Dec 2023
SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi
Silk Road Medical, Inc (SILK) Q3 2023 Earnings Call Transcript
12:37am, Thursday, 09'th Nov 2023
Silk Road Medical, Inc (NASDAQ:SILK ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Director, Investor Relations Jack Lasersohn - Ch
Silk Road Medical Reports Third Quarter 2023 Financial Results
04:05pm, Wednesday, 08'th Nov 2023
SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
06:31pm, Friday, 03'rd Nov 2023
NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are adv
Analysts Estimate Silk Road Medical (SILK) to Report a Decline in Earnings: What to Look Out for
11:19am, Wednesday, 01'st Nov 2023
Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
